Cardiovascular Toxicity Induced by Chemotherapy, Targeted Agents and Radiotherapy: ESMO Clinical Practice Guidelines

Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii155-vii166.
Authors: G. Curigliano, D. Cardinale, T. Suter, G. Plataniotis, E. de Azambuja, M. T. Sandri, C. Criscitiello, A. Goldhirsch, C. Cipolla, F. Roila

The multidisciplinary board provided recommendations on cardiovascular (CV) risk assessment and prevention in cancer patients; optimal screening and monitoring of cardiac function during cancer treatment (considering costs, feasibility and outcomes); active management of pre-existing cardiac disease to promote the most effective cancer therapy; and active management of chemotherapy, targeted agents or RT-induced cardiac toxicity.

Download the PDF from Annals of Oncology